Voyager Therapeutics Inc (NASDAQ:VYGR)
| 7.03 Delayed Data As of Nov 29 |  +0.13 / +1.88%Today’s Change | 5.27 Today|||52-Week Range 14.34 | +15.25% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 17.3M | 14.2M | 10.1M | 7.6M | |
| Depreciation And Amortization | 600.0K | 612.0K | 1.6M | 2.1M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 37.0M | 54.9M | 80.4M | 96.6M | ||
| Research And Development | 27.7M | 42.2M | 62.3M | 64.9M | ||
| Total Operating Expenses | 37.6M | 55.5M | 82.0M | 98.7M | ||
| Non-Operating Expenses | Operating Income | -20.3M | -41.3M | -71.9M | -91.1M | |
| Extraordinary Charge | -9.8M | 0.00 | 0.00 | 0.00 | ||
| Other Expenses | 0.00 | 182.0K | -62.0K | -683.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -29.7M | -40.1M | -70.7M | -88.5M | |
| Income Taxes | 0.00 | -52.0K | 0.00 | -180.0K | ||
| Preferred Dividend | -8.6M | 0.00 | 0.00 | 0.00 | ||
| Net Income | -29.7M | -40.2M | -70.7M | -88.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 4.2M | 25.3M | 26.8M | 32.1M | |
| Shares To Calculate EPS Diluted | 4.2M | 25.3M | 26.8M | 32.1M | ||
| Earnings Per Share | EPS | -$9.14 | -$1.59 | -$2.64 | -$2.75 | |
| EPS Diluted | -$9.14 | -$1.59 | -$2.64 | -$2.75 | ||
